{"name":"Air Liquide Santé International","slug":"air-liquide-sant-international","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Mix of 50% oxygen and 50% nitrogen","genericName":"Mix of 50% oxygen and 50% nitrogen","slug":"mix-of-50-oxygen-and-50-nitrogen","indication":"Supplemental oxygen therapy in anesthesia and critical care","status":"marketed"},{"name":"Kalinox 170 bar","genericName":"Kalinox 170 bar","slug":"kalinox-170-bar","indication":"Other","status":"marketed"},{"name":"sévoflurane","genericName":"sévoflurane","slug":"s-voflurane","indication":"Other","status":"marketed"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Air/Oxygen","genericName":"Air/Oxygen","slug":"air-oxygen","indication":"Hypoxemia and tissue hypoxia in various acute and chronic respiratory conditions","status":"phase_3"},{"name":"EMONO","genericName":"EMONO","slug":"emono","indication":"Acute respiratory distress syndrome (ARDS) or severe hypoxemia (Phase 3 indication pending confirmation)","status":"phase_3"}]}],"pipeline":[{"name":"Air/Oxygen","genericName":"Air/Oxygen","slug":"air-oxygen","phase":"phase_3","mechanism":"Oxygen therapy increases the concentration of oxygen available to body tissues, improving cellular oxygenation and metabolic function.","indications":["Hypoxemia and tissue hypoxia in various acute and chronic respiratory conditions","Supportive therapy in critical illness and perioperative settings"],"catalyst":""},{"name":"EMONO","genericName":"EMONO","slug":"emono","phase":"phase_3","mechanism":"EMONO is a medical gas mixture (likely nitric oxide-based) designed to improve oxygenation and reduce pulmonary hypertension in critically ill patients.","indications":["Acute respiratory distress syndrome (ARDS) or severe hypoxemia (Phase 3 indication pending confirmation)"],"catalyst":""},{"name":"Mix of 50% oxygen and 50% nitrogen","genericName":"Mix of 50% oxygen and 50% nitrogen","slug":"mix-of-50-oxygen-and-50-nitrogen","phase":"marketed","mechanism":"A 50:50 oxygen-nitrogen gas mixture provides supplemental oxygen while reducing the partial pressure of oxygen to minimize hyperoxia-related complications.","indications":["Supplemental oxygen therapy in anesthesia and critical care","Reduction of atelectasis during general anesthesia","Oxygen therapy with reduced hyperoxia risk"],"catalyst":""},{"name":"Kalinox 170 bar","genericName":"Kalinox 170 bar","slug":"kalinox-170-bar","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"sévoflurane","genericName":"sévoflurane","slug":"s-voflurane","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxQRXVaZkM0M1pzQ19sLTRVRndzZ3E3emR1RjR3bThvZmdhZk1wd1IyUE92Q2VLS0I2TFlPR0pFOUJOOG5lcHhBV2kxQTAwRmlmNUs4dk9yNDVPYTJhUEdQSmNQRWlVZlNfNlhCRnBJQnZFN1Y4aWdDZGp4VkpQLVlObW5PMWpSdGQ0cUs0VWpPNXRkUjBEOUJtRlFFV3AxWE93R1RTd0JjSm8xZXNieUpMQWxWaDktNVFyWlBqSmpBa0hpbzJNVDIxRkJSQUpha0JUQktTeDdabnF0bEZQMUlHSF82TWxyWDNUeTlmdA?oc=5","date":"2025-07-09","type":"pipeline","source":"24-7 Press Release Newswire","summary":"Marquis Who's Who Honors Marie-Louise Jacques, MD, MBA, for Global Leadership in Pharmaceutical Innovation - 24-7 Press Release Newswire","headline":"Marquis Who's Who Honors Marie-Louise Jacques, MD, MBA, for Global Leadership in Pharmaceutical Innovation - 24-7 Press ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxOTm0xdGpMQjkyVW4xOEp2TWpQUFpLUW9kOGctOWNETTYzVjdmZnZqNW1fT296d2NvMmlHMXNQRms5TFpFNDZsY0FxajNlYnpGcmNNSWxvWUtmeV9udHZadTcxNUwxcDc2ekxwendKSVp6dWgyUGRPZHVqZkNJUlkxTjhEeG5UWWJ5eUFoaE5MdU0yTjlFbThyeUJ2aUI2TDRsUGM5QzliTEk0RjRTcG5HcG45eHBtVmZIZWtiLXJOb2hjaC1peWpQeGRMUEhqRldoUy0tUVNKeWVIR0FRYzZsek9DSm5iZGlXSWg3Zms1aFkxYml3MERubG1FellhWExHTGtKSVNmY2l3RDBNX1hTQ3NjTQ?oc=5","date":"2023-11-16","type":"trial","source":"European Medical Journal","summary":"Satisfaction with Home Healthcare Provider Service in Adults with Type 1 Diabetes Using a Hybrid Closed Loop System: The SATURN Study - European Medical Journal","headline":"Satisfaction with Home Healthcare Provider Service in Adults with Type 1 Diabetes Using a Hybrid Closed Loop System: The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNRXFWQ3EzLTVmMmVENDBBZFhYVXNZN3pqVDctNFlaVEwxZVR5MUVKZjFvbVJvZk0zVjdGbnJkSXFCendnRDVNZDJvMWtDb0xGOHVzRmdxUUZBMmFIZVo0akVBUWtHQWFXVXRDS3hzam5pSUZXQVQzOGhkUUdURTl5SHFyRnQ2MnRXODBIUWRzVF91NFA0ekExaHdEdUY3MnlzVTZjWmRGeUdERVpXdTQ1QUsyOE53R1Q3Rnc?oc=5","date":"2022-09-30","type":"pipeline","source":"Clinical Pain Advisor","summary":"Interaction Between Nitrous Oxide and Opioids May Improve Neuropathic Pain - Clinical Pain Advisor","headline":"Interaction Between Nitrous Oxide and Opioids May Improve Neuropathic Pain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTFBoS2lONWFHT1BwXzFldVo0VWVRbE00SlVkMEpzV1N5SEVXcmpGRkJoWHlVR0tTblVmWFZIQlpyT0plUzZmdlNMc0VXM3B6ek5r?oc=5","date":"2022-01-28","type":"pipeline","source":"Air Liquide","summary":"Air Liquide in France - Air Liquide","headline":"Air Liquide in France","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNY0Q2UmRBSHJWSG9iNEc0X0RjU1NEbE9yOW1qUDVNNFM1R3oteWJKVk96TkhBQUJPWUlYWlZaWUxwQkozNkVFUXB4V1JOTlY0NmItRmRyYnBURE5pNEV1eDR3c3pULTB5SmhEZ1dPOWNxS0xuOWE1RkxVZ1Z3bTh4aXE3WFVYNkY4ejJUN2JaNlBueGFPc3VTdG5pcWVJaVJkVG9PX0poOVFKcjliVkZ6Uk1VYXpGSTE2S2lDbk0zZl9qckNtOTFIc3BBRDZWNF9n?oc=5","date":"2003-12-10","type":"pipeline","source":"autoritedelaconcurrence.fr","summary":"20th January 2003 : Medical gases for use in hospitals : the Conseil de la concurrence sanctions practices by two subsidiaries of the Air Liquide Group - autoritedelaconcurrence.fr","headline":"20th January 2003 : Medical gases for use in hospitals : the Conseil de la concurrence sanctions practices by two subsid","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_3":2,"marketed":3},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}